First Quadrant’s Medifast MED Stock Holding History

First Quadrant’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,859	Closed	-$394K	–	568
2021 Q1	$394K	Hold	1,859	–	–	0.04%	290
2020 Q4	$365K	Sell	1,859 -258	-12%	-$45.6K	0.04%	288
2020 Q3	$348K	Hold	2,117	–	–	0.04%	263
2020 Q2	$294K	Hold	2,117	–	–	0.04%	354
2020 Q1	$132K	Sell	2,117 -5,158	-71%	-$470K	0.02%	429
2019 Q4	$797K	Hold	7,275	–	–	0.07%	254
2019 Q3	$754K	Sell	7,275 -135	-2%	-$14.5K	0.07%	261
2019 Q2	$951K	Sell	7,410 -11	-0.1%	-$1.53K	0.07%	310
2019 Q1	$947K	Sell	7,421 -18	-0.2%	-$2.28K	0.07%	271
2018 Q4	$930K	Sell	7,439 -513	-6%	-$87.7K	0.07%	249
2018 Q3	$1.76M	Sell	7,952 -1,564	-16%	-$317K	0.04%	321
2018 Q2	$1.52M	Sell	9,516 -408	-4%	-$52.2K	0.03%	361
2018 Q1	$927K	Sell	9,924 -2,464	-20%	-$184K	0.02%	410
2017 Q4	$865K	Buy	12,388 +693	+6%	+$46K	0.02%	461
2017 Q3	$694K	Sell	11,695 -3,424	-23%	-$170K	0.01%	501
2017 Q2	$627K	Sell	15,119 -29,146	-66%	-$1.27M	0.01%	502
2017 Q1	$1.96M	Hold	44,265	–	–	0.04%	362
2016 Q4	$1.84M	Sell	44,265 -7,839	-15%	-$316K	0.04%	361
2016 Q3	$1.97M	Buy	52,104 +32,604	+167%	+$1.17M	0.04%	342
2016 Q2	$649K	Sell	19,500 -13,400	-41%	-$432K	0.01%	454
2016 Q1	$993K	Buy	32,900 +17,500	+114%	+$511K	0.02%	389
2015 Q4	$468K	Buy	+15,400	New	+$459K	0.01%	478

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

First Quadrant's MED Position: Q2 2021 in Review

First Quadrant sold out of Medifast (MED) in Q2 2021, closing a stake of 1,859 shares — an estimated $394K sold.

First Quadrant first reported a position in MED in Q4 2015 and held it in 22 quarters. The position peaked at $1.97M in Q3 2016. 301 funds tracked by Wall St. Rank hold MED as of Q2 2021.

First Quadrant reported no remaining Medifast position as of Q2 2021 after selling out during the quarter.
First Quadrant sold 1,859 Medifast shares in Q2 2021, an estimated $394K.
First Quadrant first reported a position in Medifast in Q4 2015 and held it in 22 quarters.
First Quadrant's Medifast position peaked at $1.97M in Q3 2016.
301 funds tracked by Wall St. Rank held Medifast as of Q2 2021.

Based on First Quadrant's 13F filing for Q2 2021, filed 23 Jul 2021.